These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11602854)

  • 1. Cyclosporine and long-term kidney graft survival.
    Opelz G; Döhler B
    Transplantation; 2001 Oct; 72(7):1267-73. PubMed ID: 11602854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on sandimmun neoral.
    Al Wakeel JS; Shaheen FA; Mathew MC; Abou Zeinab HM; Al Alfi A; Tarif NM; Al Mousawi MS; Mahmoud TS; Alorrayed AS; Fagir EA; Dham RS; Shaker DS
    Transplant Proc; 2008 Sep; 40(7):2245-51. PubMed ID: 18790205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low 1-year cyclosporine microemulsion doses are associated with better 5-year renal graft function: an insight from MOST, a multinational observational study.
    Salvadori M; Rosati A; Bertoni E; Bock A; Chapman J; Dussol B; Fritsche L; Kliem V; Lebranchu Y; Oppenheimer F; Pohanka E; Tufveson G; Soergel M
    Transplant Proc; 2006 May; 38(4):1010-3. PubMed ID: 16757247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind, one-year study of the safety and tolerability of cyclosporine microemulsion compared with conventional cyclosporine in renal transplant patients. International Sandimmun Neoral Study Group.
    Frei UA; Neumayer HH; Buchholz B; Niese D; Mueller EA
    Transplantation; 1998 Jun; 65(11):1455-60. PubMed ID: 9645802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term kidney transplant outcomes in patients receiving oil-based or microemulsion formulations of cyclosporine.
    Medina-Pestana JO; Felipe CR; Park SI; Machado PG; Garcia R; Spinelli G; Silva LA; Santos CF; Tedesco-Silva H
    Transplant Proc; 2004 Mar; 36(2 Suppl):74S-79S. PubMed ID: 15041311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results with cyclosporine monotherapy in renal transplant patients: a multivariate analysis of risk factors.
    Montagnino G; Tarantino A; Maccario M; Elli A; Cesana B; Ponticelli C
    Am J Kidney Dis; 2000 Jun; 35(6):1135-43. PubMed ID: 10845828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral efficacy of the macrolide immunosuppressant SDZ RAD and of cyclosporine microemulsion in cynomolgus monkey kidney allotransplantation.
    Schuurman HJ; Ringers J; Schuler W; Slingerland W; Jonker M
    Transplantation; 2000 Mar; 69(5):737-42. PubMed ID: 10755519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of cyclosporine microemulsion (neoral) versus conventional cyclosporine in liver transplantation: MILTON study. Multicentre International Study in Liver Transplantation of Neoral.
    Otto MG; Mayer AD; Clavien PA; Cavallari A; Gunawardena KA; Mueller EA
    Transplantation; 1998 Dec; 66(12):1632-40. PubMed ID: 9884251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predicting the long-term success of maintenance cyclosporine monotherapy after kidney transplantation.
    Hurault de Ligny B; Toupance O; Lavaud S; Bauwens M; Peyronnet P; Le Meur Y; Ryckelynck JP; Jolly D; Leroux-Robert C; Touchard G
    Transplantation; 2000 Apr; 69(7):1327-32. PubMed ID: 10798748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients.
    White M; Pelletier GB; Tan A; Jesina C; Carrier M
    J Heart Lung Transplant; 1997 Aug; 16(8):787-94. PubMed ID: 9286770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term renal function in heart transplant recipients receiving cyclosporine therapy.
    Goral S; Ynares C; Shyr Y; Yeoh TK; Johnson HK
    J Heart Lung Transplant; 1997 Nov; 16(11):1106-12. PubMed ID: 9402509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion to microemulsion cyclosporine in stable renal transplant patients: results after one year.
    Neumayer HH; Budde K; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J; Luft FC
    Clin Nephrol; 1996 May; 45(5):326-31. PubMed ID: 8738665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation].
    Roy A; Grant DR; Kneteman NM; Tchervenkov JI; Levy GA; Tan A; Hendricks L
    Ann Chir; 1998; 52(8):716-21. PubMed ID: 9846420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical threshold of azathioprine dosage for maintenance immunosuppression in kidney graft recipients. Collaborative Transplant Study.
    Opelz G; Döhler B
    Transplantation; 2000 Mar; 69(5):818-21. PubMed ID: 10755533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year posttransplant renal function is a strong predictor of long-term kidney function: results from the Neoral-MOST Observational Study.
    Salvadori M; Rosati A; Bock A; Chapman J; Dussol B; Fritsche L; Jeffery J; Kliem V; Lebranchu Y; Oppenheimer F; Pohanka E; Tufveson G
    Transplant Proc; 2003 Dec; 35(8):2863-7. PubMed ID: 14697923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen.
    Irish W; Sherrill B; Brennan DC; Lowell J; Schnitzler M
    Transplantation; 2003 Dec; 76(12):1686-90. PubMed ID: 14688516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine versus tacrolimus maintenance therapy in renal transplant.
    Alghamdi S; Nabi Z; Skolnik E; Alkorbi L; Albaqumi M
    Exp Clin Transplant; 2011 Jun; 9(3):170-4. PubMed ID: 21649564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion from Sandimmune to Neoral in renal transplant recipients: two-year experience.
    Wilczek HE; Akesson P; Warholm C
    Transplant Proc; 1998 Aug; 30(5):1753-5. PubMed ID: 9723267
    [No Abstract]   [Full Text] [Related]  

  • 20. Converting renal transplant patients maintained on Sandimmune to a new microemulsion formulation, Sandimmune Neoral.
    Chu SH; Pang ST; Chiang YJ; Chuang CK; Chen HW; Chen CS; Chou CC; Huang CC
    Transplant Proc; 1998 Nov; 30(7):3521-3. PubMed ID: 9838543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.